OOTOut Of Trend
An Out Of Trend result is a lab or in-process value that still sits inside its acceptance spec but is statistically unusual relative to historical performance — the earliest defensible warning that something is drifting before it ripens into an OOS. This page covers what OOT actually means, the regulatory expectation behind it (FDA 2006 OOS guidance, MHRA 2022 OOS/OOT, ICH Q9(R1), Annex 15 §6), the standard statistical rule-sets (Western Electric, Nelson, EWMA, CUSUM), how to set internal alert and action limits inside the regulatory spec, how to investigate an OOT without inflating it into a full OOS, how to trend across products and lines, and how V5 Ultimate flags OOT events live against a rolling baseline and routes them into the quality system.
01What OOT actually means
An Out Of Trend (OOT) result is a value that passes its acceptance specification but is statistically inconsistent with the historical pattern of that test, that product, that line, that instrument or that analyst. It is not a failure — the lot still meets spec — but it is an early signal that the process is drifting.
Catching OOT matters because most OOS results don't appear from nowhere. They appear after a run of inside-spec but unusual values that a basic pass/fail check ignored. OOT detection turns those silent signals into a triggered investigation before the failure occurs, while the corrective action is still cheap.
There are three flavours of OOT a regulator expects you to detect: result-level (an individual value drifting against history), stability-level (a stability lot that is degrading faster than the predicted regression), and product-quality (a release attribute drifting across multiple batches even though every batch is in spec). Most quality systems handle the first poorly, the second somewhat, and the third almost never — which is why warning letters often cite OOT as a missing element rather than a broken one.
02Where OOT is mandated
OOT is not its own regulation — it is required by several quality-system clauses across multiple jurisdictions:
| Regulation / guidance | What it requires | OOT relevance |
|---|---|---|
| FDA 2006 OOS Guidance §V | Trend evaluation of laboratory data; investigation of unusual but in-spec results | Establishes the regulator's expectation that OOT be detected, investigated and documented |
| MHRA 2022 OOS/OOT | Explicit OOT category alongside OOS; documented evaluation required even when no CAPA is opened | Tightest published expectation; widely treated as the global baseline |
| 21 CFR 211.180(e) | Annual product review including trend analysis of in-process and finished-product results | OOT is the operational mechanism that makes APR trend analysis defensible |
| EU GMP Chapter 1 §1.10(iv) | PQR must review trends of in-process control results, finished product, complaints and OOS | OOT events are the input data to the PQR |
| EU GMP Annex 15 §6 — Ongoing Process Verification | Statistical trending of process parameters and quality attributes throughout the lifecycle | Stage 3 process validation depends on OOT detection working continuously |
| FDA Process Validation Guidance Stage 3 (2011) | Continued process verification with statistical control | Same Stage 3 expectation as Annex 15 §6 |
| ICH Q9(R1) | Risk-based decision making for quality events | OOT triage uses Q9 risk methodology |
| ICH Q10 | Continual improvement of process performance and product quality | OOT is the early-warning input to Q10's improvement loop |
| USP <1010> | Statistical treatment of analytical data including outlier evaluation | Provides the statistical underpinning used in many OOT decisions |
The combined effect: even though no single sentence says "you must have an OOT system," running a GMP plant without one is indefensible. Auditors raise it under whichever clause the inspector reaches first.
03OOT vs OOS — the operational difference
| OOT | OOS | |
|---|---|---|
| Spec status | Inside spec | Outside spec |
| Trigger | Statistical rule on the trend or breach of internal alert/action limit | Acceptance criterion (regulatory spec) breached |
| Disposition impact | None directly — lot may still release pending evaluation | Lot quarantined pending investigation |
| Investigation depth | Trend-focused, lower urgency, can sometimes close on documented evaluation | Formal OOS investigation per FDA 2006 (Phase Ia/Ib/II) |
| Documentation requirement | Documented evaluation always required, even if no CAPA | Formal investigation report, root cause, impact assessment on other batches |
| Outcome if confirmed | Process adjustment, CAPA if recurring, possible re-validation | Disposition decision + CAPA + cross-batch impact + supplier/regulator notifications as required |
| Reporting lifeline | Annual Product Review / PQR trend section | OOS log + APR/PQR + regulator (e.g. Field Alert Report within 3 working days for marketed drugs) |
The single biggest operational confusion: an OOT investigation is not a "mini-OOS". It uses different decision logic, different urgency, and different scientific tools. Forcing every OOT through the OOS template gives investigators alert fatigue, which is how genuine early signals get buried in the noise.
04Internal alert and action limits
The cleanest way to operationalise OOT is to establish two internal limits inside the regulatory specification:
- Alert limit — typically 2σ from the historical mean, or 80% of the way from mean to spec. Crossing it produces an OOT signal and a documented evaluation, but no production stop.
- Action limit — typically 3σ, or 90% of the way from mean to spec. Crossing it triggers a more formal investigation, often with a production hold pending root cause.
- Specification limit — the regulatory limit. Crossing it is an OOS by definition.
| Limit | Set how | Trigger | Action |
|---|---|---|---|
| Alert | μ ± 2σ from rolling baseline, or 80% to spec | OOT-level event | Documented evaluation; trend watch; no hold required |
| Action | μ ± 3σ, or 90% to spec | OOT-level event with higher severity | Investigation; consider hold; engineering review |
| Spec | Regulatory / pharmacopoeial limit | OOS by definition | Formal OOS investigation per FDA 2006 |
Choosing the right limits matters more than choosing the right statistical rule. Limits set too tight drown the system in false signals; limits set too loose let drifts run until they crash through the spec. The standard discipline is to re-baseline annually as part of the PQR, using only data from in-control periods.
05How OOT is detected statistically
OOT detection is statistical — you cannot eyeball it reliably. The two standard rule-sets are the Western Electric rules and the more conservative Nelson rules, applied to SPC charts (X-bar/R, individuals, EWMA, CUSUM) built off historical data.
Western Electric rules (the classic eight)
- Rule 1 — one point beyond ±3σ of the mean (single-point breach).
- Rule 2 — two of three consecutive points beyond ±2σ on the same side.
- Rule 3 — four of five consecutive points beyond ±1σ on the same side.
- Rule 4 — eight consecutive points on the same side of the mean (sustained shift).
- Rule 5 — six consecutive points trending up or down (drift).
- Rule 6 — fifteen consecutive points within ±1σ (stratification / overcontrol).
- Rule 7 — fourteen alternating up/down (systematic).
- Rule 8 — eight consecutive points outside ±1σ on either side (mixture).
Nelson rules (the modern, slightly stricter alternative)
Nelson's eight rules tighten the Western Electric set, particularly around shift and trend detection. The trade-off is sensitivity vs false alarms — Nelson rules find drifts sooner but raise more flags.
EWMA and CUSUM (for small persistent shifts)
Exponentially Weighted Moving Average and Cumulative Sum charts are designed for the small shifts (~0.5σ to 1.5σ) that Western Electric / Nelson rules miss. They are essential for stability-indicating assays and for attributes where the regulatory spec is wide but drift still matters.
06Investigating an OOT — the standard playbook
- Confirm the result is real — not a transcription error, not a recently re-calibrated instrument, not a method change, not an analyst variance.
- Check the chain — instrument calibration status, reference standard lot, mobile-phase prep date, column age, balance verification, analyst training currency.
- Look for assignable cause — change in raw material lot, operator, equipment, environmental conditions (T/RH), supplier, software version.
- Determine if the same trend appears in related products / lines / instruments — single-point oddity vs systemic shift.
- Decide on action — monitor (continue, watch closely), adjust (re-calibrate, swap raw-material lot), escalate (open CAPA, halt production).
- Document the investigation, even if the outcome is "continue to monitor" — the documented rationale is the deliverable.
- Feed the event into the next PQR / APR trend section so it is reviewed in the annual context.
MHRA's 2022 OOT guidance is explicit that not every OOT requires a CAPA, but every OOT must be evaluated and the evaluation documented. "Filed under no further action" without a written rationale is a finding.
07Trending across product, line and time
A single OOT is informational. A pattern of OOTs is intelligence. The valuable trending dimensions are:
- Per product — drift signals a material or formulation issue.
- Per line / equipment — drift signals an asset condition issue (often a precursor to breakdown).
- Per shift / operator — drift signals a training or SOP-compliance issue.
- Per supplier lot of a critical raw material — drift signals an incoming-material variability issue.
- Per analyst / per instrument — drift signals a method robustness or analyst calibration issue.
- Per season — drift signals an HVAC or storage condition issue.
These trends are normally only visible in the Annual Product Review / Product Quality Review, which is exactly why APR/PQR exists. A working OOT system feeds the APR with structured, queryable events — not a list of paper investigation packets to manually re-summarise.
08Where OOT fits in the quality system
OOT lives in the lab and quality systems alongside OOS, deviations, NCRs, complaints, change controls and CAPAs. The relationship matters:
- Single OOT, assignable cause found, action taken — documented and closed.
- Multiple OOTs on the same trend — escalate to CAPA, treat as process drift.
- OOT that turns into an OOS — escalate to OOS investigation under FDA's 2006 guidance, with the OOT history as background.
- OOT pattern across multiple products — escalate to a broader process review (e.g. utility, environmental, supplier).
- OOT correlated with a change control — feed back into the change-control effectiveness check.
09Common OOT failures
- No OOT system at all — only OOS gets investigated; the warning signal is lost.
- OOT alert limits set so tight that the noise drowns the signal — analysts develop alert fatigue.
- OOT alert limits set so loose that nothing trips until OOS.
- OOT events captured but not trended across products / lines.
- OOT investigations closed without a documented rationale.
- OOT system uses static limits never recomputed against current data — drift goes undetected because the baseline drifted with it.
- OOT events held in a separate spreadsheet outside the QMS — invisible to the APR.
- Stability OOT (lot degrading faster than the regression predicts) ignored because the lot is still in spec.
- OOT trigger thresholds never reviewed in the PQR, so the system can't tell whether the limits are still appropriate.
- OOT events not tied to the relevant batch record, so traceability is broken.
10Statistical techniques for OOT detection
OOT detection is only as good as the statistical method behind the alert. Three families dominate, each with different sensitivity to different drift patterns:
| Technique | What it catches | What it misses | Best fit |
|---|---|---|---|
| Shewhart 3σ + Western Electric rules | Step changes ≥ 1.5σ within ~8 points; sustained mean shift | Slow drifts < 0.5σ per point | High-volume in-process data (tablet weight, assay) |
| EWMA (exponentially weighted moving average) | Small persistent drifts (0.25–0.75σ) | Fast spikes | Stability data, environmental monitoring trends |
| CUSUM (cumulative sum) | Smallest persistent mean shifts; earliest detection of drift | Less intuitive for operators to read | Continuous process verification, raw-material lot drift |
| Linear regression vs predicted | Stability OOT — lot degrading faster than the model | Non-linear degradation | Stability programmes (assay, related substances, moisture) |
| Capability ratio (Cpk / Ppk) trend | Process losing margin against the spec even while all points stay in | Single-point excursions | Quarterly PQR / APR aggregations |
Mature OOT programmes layer at least two techniques: Shewhart + Western Electric for the operator-facing real-time alarm (fast feedback, intuitive), and EWMA or CUSUM for the QA-facing weekly trend review (catches drifts the Shewhart chart misses). Stability data sits separately under the regression model. Running only one technique guarantees a class of misses.
The Western Electric rules — 2 of 3 points beyond 2σ on the same side, 4 of 5 points beyond 1σ on the same side, 8 consecutive points on the same side of the mean, 6 increasing or decreasing — are the operational backbone of Shewhart-based OOT for regulated manufacturers. Codify them in the OOT SOP, not in tribal knowledge, and ensure the system fires alerts on each rule independently so the investigator knows which pattern triggered.
11OOT investigation workflow and decision rules
The investigation workflow that holds up under inspection has clear decision points and explicit acceptance criteria for each disposition. The MHRA 2022 guidance on OOT / OOE / OOS expects to see this sequence documented:
- Trigger captured — system records the event with rule fired, points involved, asset, lot, operator, timestamp, and links to the upstream batch / EM / stability record.
- Confirmation review (within 24 hours) — QA confirms the event isn't an obvious data-entry or instrument fault. If it is, the event is reclassified (laboratory error, not OOT) with rationale.
- Assignable-cause investigation (within 5 working days for in-process, 10 for stability) — production / process engineering investigate. Output is one of four dispositions: assignable cause found; no assignable cause but explained by known variability; trend confirmed → CAPA; trend confirmed → re-baseline limits.
- Disposition signed by QA — explicit rationale, not 'reviewed and accepted'. 'No assignable cause' is a legitimate outcome but must be supported by the data review, not by silence.
- Aggregation review (monthly) — all OOT events of the period reviewed together for cluster patterns the individual investigations couldn't see (same operator across products, same shift across lines, same instrument across analytes).
- PQR / APR roll-up (annually) — OOT rate per product / parameter trended year-over-year. Trigger limits reviewed; control limits recalculated where the underlying distribution has shifted intentionally (e.g. after a validated process change).
The two failure modes that kill the workflow: 'reviewed and accepted' as a closing comment without rationale, and a backlog of open OOT events older than the SOP-defined investigation window. Both are common 483 / Form-EU GMP findings — they signal that the trending programme exists on paper but is not being operated.
12OOT in stability programmes
Stability is where OOT most often catches real problems before they become OOS — a lot degrading faster than the regression model predicts is a powerful early warning of formulation, packaging or storage issues, weeks or months before the spec limit is reached. ICH Q1E provides the statistical foundation: fit a regression to the stability data, calculate the 95% confidence interval, and any time-point that falls outside the predicted interval (even while still inside the regulatory spec) is a stability OOT.
Three patterns are diagnostic:
- Single lot degrading faster than the model with no peers — usually an investigation into that specific lot (manufacturing deviation, packaging fault, storage excursion).
- Multiple recent lots degrading faster than the historical model — a process or material change that hasn't been caught by change control. Investigate raw-material supplier change, equipment maintenance, environmental shift.
- All lots degrading along the model but the model intercept is shifting — the assay or impurity method itself may have drifted. Investigate method robustness, reference standard, analyst.
The 'lot is still in spec' argument is the most dangerous failure mode in stability OOT. Regulators have stated explicitly (FDA Compliance Program 7346.832, MHRA 2022) that a lot degrading faster than predicted is a quality signal regardless of where the absolute value sits. Ignoring it because the spec hasn't been breached is the same logic as ignoring an in-process trend at the alert limit — both miss the point of trending.
Frequently asked questions
Q.Is every OOT a deviation?+
No. A deviation is a departure from procedure or spec. An OOT is a within-spec statistical anomaly. They may overlap (a process drift can lead to both), but they are distinct events with distinct workflows.
Q.Do I need to open a CAPA for every OOT?+
No. CAPA is triggered when investigation confirms a recurring or systemic cause. A one-off explained by an assignable cause does not need a CAPA on its own. MHRA's 2022 guidance is explicit on this point.
Q.Who owns OOT investigations?+
Typically QC for the data investigation and Production / Process Engineering for the cause investigation, with QA review for the disposition. The QA disposition is what closes the event.
Q.Can I set my alert limit equal to the regulatory spec?+
Technically yes, but that means you have no early warning system — you've just renamed OOS. Internal alert limits exist to fire before the spec is breached.
Q.How often should I re-baseline the limits?+
At minimum annually as part of the PQR. Some organisations re-baseline quarterly for high-volume products, or after any change control that could shift the underlying distribution.
Q.Does OOT apply to environmental monitoring data?+
Yes — and in many GMP plants this is where OOT generates the most actionable signal. Trending viable counts before they break action limits is the entire point of an EM programme.
Q.How does OOT relate to Stage 3 Continued Process Verification?+
OOT is the operational mechanism that makes Stage 3 work. Without OOT, you can document that a parameter stayed in spec, but you cannot demonstrate that the process remained in a state of control — which is the actual Stage 3 expectation.
Q.Should the same person who detected an OOT investigate it?+
No. Detection is QC's job; investigation is production / process engineering with QA oversight. Same-person workflows are a documented data-integrity risk because they conflate the analytical confirmation step with the cause-finding step. Most QMS systems enforce role separation at the system level for this reason.
Q.How do I handle an OOT on a parameter that is monitored but not specified?+
Identically to a specified parameter — the regulatory expectation in MHRA 2022 and FDA's Stage 3 CPV guidance is that any monitored parameter participates in trending, whether or not it has a release spec. Practically, that means setting internal alert + action limits on monitored-only parameters and investigating excursions even when nothing is technically out of spec. The auditor will ask why the parameter is monitored if you don't act on its signal.
Q.Can machine-learning anomaly detection replace Shewhart-style OOT?+
Only as a layer above, not as a replacement. ML methods catch multivariate patterns Shewhart misses, but for regulated decision-making the underlying statistical rules must be transparent and reproducible. Most validated programmes use ML for screening high-dimensional data (continuous process verification across 50+ tags) and Shewhart / EWMA / CUSUM for the parameters that drive release dispositions.
Q.What's a typical OOT rate to expect?+
For a well-controlled process at 3σ control limits, the natural false-alarm rate is roughly 1 in 370 points (0.27%) per Shewhart rule. Layering Western Electric rules raises detected events to ~1–2% of points. If your detected rate is much lower, your limits are probably too wide; much higher, the underlying process is genuinely drifting and the conversation moves from 'investigate each' to 'fix the process'.
Primary sources
Further reading
Explore this topic
OOT sits inside 3 overlapping topic clusters in our glossary. Every neighbour is one click away.
Drug-product cGMP rules, ICH Q-series, and the regulators that enforce them.
Root-cause toolkit, SPC, capability and the rest of the QA practitioner's bench.
V5 Ultimate ships with the OOT controls already wired in — audit trail, e-signatures, validation evidence. Free trial, no credit card, onboard in days, not months.
